Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Poseida Therapeutics Inc (NQ: PSTX )

2.730 +0.020 (+0.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Form SC 13D/A
Source: SEC/Edgar
June 04, 2014
Form 15-12B
Source: SEC/Edgar
March 26, 2014
Form SC 13D/A
Source: SEC/Edgar
March 26, 2014
Form EFFECT
Source: SEC/Edgar
March 24, 2014
Form EFFECT
Source: SEC/Edgar
March 24, 2014
Form S-8 POS
Source: SEC/Edgar
March 23, 2014
Form POS AM
Source: SEC/Edgar
March 23, 2014
Form S-8 POS
Source: SEC/Edgar
March 23, 2014
Form 8-K
Source: SEC/Edgar
March 23, 2014
Form S-8 POS
Source: SEC/Edgar
March 23, 2014
Form S-8 POS
Source: SEC/Edgar
March 23, 2014
Form POS AM
Source: SEC/Edgar
March 23, 2014
Form 8-K
Source: SEC/Edgar
March 20, 2014
Form 8-K
Source: SEC/Edgar
March 10, 2014
Form DEFA14A
Source: SEC/Edgar
March 10, 2014
Form DEFM14A
Source: SEC/Edgar
February 24, 2014
Form SC 13D/A
Source: SEC/Edgar
February 04, 2014
Form SC 13D/A
Source: SEC/Edgar
January 26, 2014
Form SC 13D/A
Source: SEC/Edgar
January 22, 2014
Form PREM14A
Source: SEC/Edgar
January 21, 2014
Form SC 13D
Source: SEC/Edgar
January 09, 2014
Form SC 13D/A
Source: SEC/Edgar
January 06, 2014
Form SC 13D/A
Source: SEC/Edgar
January 06, 2014
Form 8-K
Source: SEC/Edgar
January 01, 2014
Form DEFA14A
Source: SEC/Edgar
January 01, 2014
Form 8-K
Source: SEC/Edgar
December 30, 2013
Form 424B3
Source: SEC/Edgar
December 03, 2013
Form 8-K
Source: SEC/Edgar
December 02, 2013
Form 8-K
Source: SEC/Edgar
November 21, 2013
Form 8-K
Source: SEC/Edgar
November 13, 2013
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.